Sugentech KRX:253840KOSDAQ

수젠텍 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11

In Q2 2026, Sugentech reported revenue of ₩3.1bn, down 2.8% year on year, and an operating loss of ₩4.2bn. Sugentech (수젠텍) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 1 article.

Sugentech quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩3.1bn-2.8%−₩4.2bn−₩3.8bn
Q1 2026₩2.3bn+24.2%−₩4.7bn−₩4.3bn
Q4 2025 derived₩2.9bn+16.4%−₩5.1bn−₩11.3bn
Q3 2025₩1.5bn-63.9%−₩4.8bn−₩3.8bn
Q2 2025₩3.2bn+103.8%−₩4.9bn−₩5.3bn
Q1 2025₩1.9bn-3.6%−₩4.0bn−₩3.1bn
Q4 2024 derived₩2.5bn+18.8%−₩7.7bn−₩8.8bn
Q3 2024₩4.1bn+177.2%−₩4.4bn−₩4.3bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Sugentech top stories 2 weeks, by number of outlets

  1. 1
    마이코플라스마 폐렴 재유행… 수젠텍, 체외진단 라인업 가치 부각
    1 outlets · 1 articlesFirst report Sep 14 10:46 핀포인트뉴스

Latest Sugentech news Korean headlines